Keyphrases
Hepatitis B Surface Antigen (HBsAg)
100%
Chronic HBV Infection
100%
Quasispecies
100%
Hepatitis B e Antigen (HBeAg)
100%
REP 2139
100%
Non-responders
57%
Major Hydrophilic Region
42%
HBV Quasispecies
28%
Clinical Manifestations
14%
Immune Response
14%
Upstream Open Reading Frame (uORF)
14%
Viral
14%
Substantial Reduction
14%
Dynamic Change
14%
Diagnostic Test
14%
Functional Control
14%
New Antivirals
14%
Nucleic Acid Polymer
14%
Hepatitis B Treatment
14%
Seroconversion
14%
Antiviral Drugs
14%
Nucleos(t)ide Analogues
14%
HBV DNA
14%
Specific mutation
14%
Infection Control
14%
Peginterferon
14%
Pre-S
14%
Long-term Administration
14%
Quasispecies Complexity
14%
Viral Particles
14%
Medicine and Dentistry
Hepatitis B Virus
100%
Infection
100%
Hepatitis B Antigen
100%
Hepatitis B(e) Antigen
100%
Quasispecies
100%
Diagnosis
16%
Immune Response
16%
Nucleic Acid
16%
Seroconversion
16%
Hepatitis B Antibody
16%
Peginterferon
16%
Hepatitis B Treatment
16%
Immunotherapy
16%
Open Reading Frame
16%
Antiviral Drug
16%
Immunology and Microbiology
HBsAg
100%
Hepatitis B Virus
100%
Quasispecies
100%
Hepatitis B(e) Antigen
100%
Hepatitis B Antigen
100%
Pegylated Interferon
16%
Immune Response
16%
Seroconversion
16%
Hepatitis B Surface Antibody
16%
Immunotherapy
16%
Open Reading Frame
16%
Hepatitis B
16%
HBV DNA
16%
Biochemistry, Genetics and Molecular Biology
HBeAg
100%
Hepatitis B Virus
100%
Quasispecies
100%
HBsAg
100%
Nucleic Acid
16%
Immune Response
16%
Seroconversion
16%
Open Reading Frame
16%
Interferon
16%
Neuroscience
Hepatitis B(e) Antigen
100%
Hepatitis B Antigen
100%
Open Reading Frame
16%
Nucleic Acid
16%
Pegylated Interferon
16%
Hepatitis B Surface Antibody
16%
Immunotherapy
16%